The Interactive Content team within Information Services designed and published the ASPIRING study website on behalf of Professor Rustam Al-Shahi Salman from the CCBS (Centre for Clinical Brain Sciences, University of Edinburgh).
This multi-component project includes a patient recruitment portal (Drupal 10) multilingual videos (Media Hopper Create), investigator training materials (H5P interactive content), and a technical collaboration with developers from ECTU (Edinburgh Clinical Trials Unit) who are responsible for the participant database.
Accessibility requirements
An important design consideration was the specific web accessibility needs of stroke survivors, who may have physical, sensory, or cognitive impairments.
In real terms, this means allowing website visitors to:
- Navigate most of the website using just a keyboard
- Magnify all content to 300% without loss of content
- Listen to most of the website using a screen reader (including the most recent versions of JAWS, NVDA and VoiceOver)
- Navigate most of the website using screen recognition software e.g. Dragon
- Experience no time limits
Positive feedback
One of the funding agencies, British Heart Foundation (BHF), kindly provided very positive feedback and requested their logo be included on the website.
BHF currently link to ASPIRING through the ‘Active GCRFF trials’ page on their website.
Trials endorsed by the GCRFF Multinational Clinical Trials Initiative
About the study
Antiplatelet Secondary Prevention International Randomised study after INtracerebral haemorrhaGe
ASPIRING is an international study, testing whether aspirin and clopidogrel prevent strokes, heart attacks, and death after brain haemorrhage. This study, run by The University of Edinburgh and NHS Lothian, will include more than 4,000 people with brain haemorrhage.
Leave a Reply